CD5 - Revision history

John at 19:36, 4 July 2023

2023-07-04T19:36:02Z

← Older revision		Revision as of 21:36, 4 July 2023
Line 69:		Line 69:
	\|-		\|-
	!colspan="8"\|'''Expression in mature B cell neoplasms'''		!colspan="8"\|'''Expression in mature B cell neoplasms'''
	\|-		\|- <span style="font-size:70%">
	! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL		! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL \|\| LPL !! PCL
	\|-		\|-<span style="font-size:70%">
	\|style="width: 12.5%; background: #004466; color:white"\|80-100%		\|style="width: 12.5%; background: #004466; color:white"\|80-100%
	\|style="width: 12.5%; background: #004466; color:white"\|80-100%		\|style="width: 12.5%; background: #004466; color:white"\|80-100%

John at 20:38, 17 June 2023

2023-06-17T20:38:32Z

← Older revision		Revision as of 22:38, 17 June 2023
Line 48:		Line 48:
	{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="8"\|~~<span style="font-size:100%">~~'''Expression in primitive cell types'''</font>		!colspan="8"\|'''Expression in primitive cell types'''</font>
	\|-		\|- <span style="font-size:70%">
	! AML !! CMML !! B ALL !! ~~Burkitt~~ \|\| T ALL !! ETP ALL ~~<'''[[ETP ALL\|I]]'''>~~ !! ~~MPAL <'''[[~~MPAL~~\|I]]'''>~~ \|\| ~~Hgns~~ <~~'''[[Hgns\|I]]'''~~>		!AML!!CMML !!B ALL !!BL \|\|T ALL !!ETP ALL !!MPAL \|\|Hgn</span>
	\|-		\|-<span style="font-size:70%">
	\|style="width: 12.5%; background: #66e0ff; color:black"\|5-20%		\|style="width: 12.5%; background: #66e0ff; color:black"\|5-20%
	\|style="width: 12.5%; background: #66e0ff; color:black"\|CMML		\|style="width: 12.5%; background: #66e0ff; color:black"\|CMML

John at 15:14, 6 May 2023

2023-05-06T15:14:11Z

← Older revision		Revision as of 17:14, 6 May 2023
Line 63:		Line 63:
	\|}		\|}

	<span style="font-size:90%">'''Notes:''' CD5 is a useful marker of T-lineage in acute leukaemia although not absolutely specific. Dim expression in ETP-ALL is useful dagnostically. It is also expressed on late stage haematogones </span>		<span style="font-size:90%">'''Notes:''' CD5 is a useful marker of T-lineage in acute leukaemia although not absolutely specific. Dim expression in ETP-ALL is useful dagnostically. There may be weak expression on AML and CMML in some cases. It is also expressed on late stage haematogones </span>

John at 15:09, 6 May 2023

2023-05-06T15:09:30Z

← Older revision		Revision as of 17:09, 6 May 2023
Line 46:		Line 46:


	{\| class=wikitable style="text-align: center; font-size:80%; width: ~~87.5~~%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="7"\|<span style="font-size:100%">'''Expression in primitive cell types'''</font>		!colspan="8"\|<span style="font-size:100%">'''Expression in primitive cell types'''</font>
	\|-		\|-
	! AML !! B ALL !! Burkitt \|\| T ALL !! ETP ALL ('''[[ETP ALL\|i]]''') !! MPAL '''[[MPAL\|i]] \|\| Hgns '''[[Hgns\|i]]'''		! AML !! CMML !! B ALL !! Burkitt \|\| T ALL !! ETP ALL <'''[[ETP ALL\|I]]'''> !! MPAL <'''[[MPAL\|I]]'''> \|\| Hgns <'''[[Hgns\|I]]'''>
	\|-		\|-
	\|style="width: 14.25%; background: #66e0ff; color:black"\|5-20%		\|style="width: 12.5%; background: #66e0ff; color:black"\|5-20%
	\|style="width: 14.25%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #66e0ff; color:black"\|CMML
	\|style="width: 14.25%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.25%; background: #006699; color:white"\|40-80%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.25%; background: #006699; color:white"\|40-80% '''DIM'''		\|style="width: 12.5%; background: #006699; color:white"\|40-80%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #006699; color:white"\|40-80% '''DIM'''
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%
			\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%
	\|-		\|-
	\|}		\|}

John at 18:25, 30 April 2023

2023-04-30T18:25:26Z

← Older revision		Revision as of 20:25, 30 April 2023
Line 82:		Line 82:
	\|}		\|}

	<span style="font-size:90%">'''Notes:''' ~~xxxxx~~ </span>		<span style="font-size:90%">'''Notes:''' Expression of CD5 in matureB cells is strongly suggestive of either CLL or MCL, however it is not exclusive to those disorders so care ful examination of overall marker profiles is essential.</span>


Line 100:		Line 100:
	\|}		\|}

	<span style="font-size:90%">'''Notes:''' ~~xxxxx~~ </span>		<span style="font-size:90%">'''Notes:''' CD5 is consitently expressed in mature T cell malignancies but not in NK lineage.</span>

	~~----~~

	~~Expression by mature T-cell disorders~~

	----		----

John at 18:14, 30 April 2023

2023-04-30T18:14:46Z

← Older revision		Revision as of 20:14, 30 April 2023
Line 96:		Line 96:
	\|style="width: 14.25%; background: #004466; color:white"\|80-100%		\|style="width: 14.25%; background: #004466; color:white"\|80-100%
	\|style="width: 14.25%; background: #004466; color:white"\|80-100%		\|style="width: 14.25%; background: #004466; color:white"\|80-100%
	\|style="width: 14.25%; background: 5#E6FAFF; color:black"\|<5%		\|style="width: 14.25%; background: #E6FAFF; color:black"\|<5%
	\|-		\|-
	\|}		\|}
Line 106:		Line 106:
	Expression by mature T-cell disorders		Expression by mature T-cell disorders

	~~<gallery widths="40px" heights="40px" >~~
	~~File:Hi.png\|frame\|''T-PLL''\|link=Flow cytometry key~~
	~~File:Hi.png\|''T-LGL''\|link=Flow cytometry key~~
	~~File:Rare.png\|''NK-LGL''\|link=Flow cytometry key~~
	~~File:Hi.png\|''ATLL'' *\|link=Flow cytometry key~~
	~~File:Hi.png\|''Sezary'' *\|link=Flow cytometry key~~
	~~File:Freq.png\|''Others'' **\|link=Flow cytometry key~~
	~~</gallery>~~

	~~<span style="font-size:80%">'''*''' expression may be dim</span>~~

	~~<span style="font-size:80%">'''**''' a range of other T cell disorders may circulate occasionally, marker expression varies</span>~~
	----		----

John at 18:14, 30 April 2023

2023-04-30T18:14:01Z

← Older revision		Revision as of 20:14, 30 April 2023
Line 94:		Line 94:
	\|style="width: 14.25%; background: #004466; color:white"\|80-100%		\|style="width: 14.25%; background: #004466; color:white"\|80-100%
	\|style="width: 14.25%; background: #004466; color:white"\|80-100%		\|style="width: 14.25%; background: #004466; color:white"\|80-100%
	\|style="width: 14.25%; background: ~~?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100~~#004466; color:white ~~black~~"\|~~? <5% 5-20% 20-40% 40-80%~~ 80-100%		\|style="width: 14.25%; background: #004466; color:white"\|80-100%
	\|style="width: 14.25%; background: ~~?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100~~#004466; color:white ~~black~~"\|~~? <5% 5-20% 20-40% 40-80%~~ 80-100%		\|style="width: 14.25%; background: #004466; color:white"\|80-100%
	\|style="width: 14.25%; background: ~~?#FFE4E1~~ 5#E6FAFF ~~20#66e0ff 40#00b8e6 80#006699;100#004466~~; color:~~white~~ black"\|? <5~~% 5-20% 20-40% 40-80% 80-100~~%		\|style="width: 14.25%; background: 5#E6FAFF; color:black"\|<5%
	\|-		\|-
	\|}		\|}

John at 18:11, 30 April 2023

2023-04-30T18:11:32Z

@@ Line 92: / Line 92: @@
 ! ATLL !! CTCL/Sezary !! T-PLL !! T-LGL !! NK-LGL
 |-
-|style="width: 14.25%; background: 100#004466; color:white"|80-100%
+|style="width: 14.25%; background: #004466; color:white"|80-100%
-|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
+|style="width: 14.25%; background: #004466; color:white"|80-100%
 |style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
 |style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"|? <5% 5-20% 20-40% 40-80% 80-100%
@@ Line 103: / Line 103: @@
 ----
 Expression by mature T-cell disorders

John at 18:05, 30 April 2023

2023-04-30T18:05:30Z

← Older revision		Revision as of 20:05, 30 April 2023
Line 92:		Line 92:
	! ATLL !! CTCL/Sezary !! T-PLL !! T-LGL !! NK-LGL		! ATLL !! CTCL/Sezary !! T-PLL !! T-LGL !! NK-LGL
	\|-		\|-
	\|style="width: 14.25%; background: ~~?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;~~100#004466; color:white ~~black~~"\|~~? <5% 5-20% 20-40% 40-80%~~ 80-100%		\|style="width: 14.25%; background: 100#004466; color:white"\|80-100%
	\|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"\|? <5% 5-20% 20-40% 40-80% 80-100%		\|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"\|? <5% 5-20% 20-40% 40-80% 80-100%
	\|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"\|? <5% 5-20% 20-40% 40-80% 80-100%		\|style="width: 14.25%; background: ?#FFE4E1 5#E6FAFF 20#66e0ff 40#00b8e6 80#006699;100#004466; color:white black"\|? <5% 5-20% 20-40% 40-80% 80-100%

John at 18:04, 30 April 2023

2023-04-30T18:04:16Z

← Older revision		Revision as of 20:04, 30 April 2023
Line 86:		Line 86:


	{\| class=wikitable style="text-align: center; font-size:80%; width: 71.4%; height 40px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 62.4%; height 40px;"
	\|-		\|-
	!colspan="7"\|'''Expression in mature T cell neoplasms*'''		!colspan="7"\|'''Expression in mature T cell neoplasms*'''

← Older revision		Revision as of 17:09, 6 May 2023
Line 46:		Line 46:


	{\| class=wikitable style="text-align: center; font-size:80%; width: ~~87.5~~%; height 20px;"		{\| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
	\|-		\|-
	!colspan="7"\|<span style="font-size:100%">'''Expression in primitive cell types'''</font>		!colspan="8"\|<span style="font-size:100%">'''Expression in primitive cell types'''</font>
	\|-		\|-
	! AML !! B ALL !! Burkitt \|\| T ALL !! ETP ALL ('''[[ETP ALL\|i]]''') !! MPAL '''[[MPAL\|i]] \|\| Hgns '''[[Hgns\|i]]'''		! AML !! CMML !! B ALL !! Burkitt \|\| T ALL !! ETP ALL <'''[[ETP ALL\|I]]'''> !! MPAL <'''[[MPAL\|I]]'''> \|\| Hgns <'''[[Hgns\|I]]'''>
	\|-		\|-
	\|style="width: 14.25%; background: #66e0ff; color:black"\|5-20%		\|style="width: 12.5%; background: #66e0ff; color:black"\|5-20%
	\|style="width: 14.25%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #66e0ff; color:black"\|CMML
	\|style="width: 14.25%; background: #E6FAFF; color:black"\|<5%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.25%; background: #006699; color:white"\|40-80%		\|style="width: 12.5%; background: #E6FAFF; color:black"\|<5%
	\|style="width: 14.25%; background: #006699; color:white"\|40-80% '''DIM'''		\|style="width: 12.5%; background: #006699; color:white"\|40-80%
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #006699; color:white"\|40-80% '''DIM'''
	\|style="width: 14.25%; background: #00b8e6; color:black"\|20-40%		\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%
			\|style="width: 12.5%; background: #00b8e6; color:black"\|20-40%
	\|-		\|-
	\|}		\|}